These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18055394)

  • 1. [Role of obesity in colorectal carcinogenesis].
    Hagymási K; Tulassay Z
    Orv Hetil; 2007 Dec; 148(51):2411-6. PubMed ID: 18055394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin and Intelectin-1: Important Adipokine Players in Obesity-Related Colorectal Carcinogenesis.
    Kawashima K; Maeda K; Saigo C; Kito Y; Yoshida K; Takeuchi T
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
    Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and its association with colorectal cancer: a review.
    Siddiqui AA
    Am J Med Sci; 2011 Mar; 341(3):227-31. PubMed ID: 20460980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The metabolic syndrome and type-2 diabetes mellitus as conditions predisposing for malignant tumors].
    Halmos T; Suba I
    Orv Hetil; 2008 Dec; 149(51):2403-11. PubMed ID: 19073451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Roles of metabolic syndrome and insulin resistance in carcinogenesis of colon].
    Lü BJ; Lai MD
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):110-2. PubMed ID: 16630487
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic syndrome: a novel high-risk state for colorectal cancer.
    Ishino K; Mutoh M; Totsuka Y; Nakagama H
    Cancer Lett; 2013 Jun; 334(1):56-61. PubMed ID: 23085010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women.
    Gaspard U
    Maturitas; 2009 Apr; 62(4):362-5. PubMed ID: 19131194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, type 2 diabetes and risk of digestive cancer.
    Hillon P; Guiu B; Vincent J; Petit JM
    Gastroenterol Clin Biol; 2010 Oct; 34(10):529-33. PubMed ID: 20864282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetes and cancer risk: oncologic considerations].
    Rosta A
    Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diet, lifestyle, and colorectal cancer: is hyperinsulinemia the missing link?
    Kim YI
    Nutr Rev; 1998 Sep; 56(9):275-9. PubMed ID: 9763878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlations of insulin resistance and neoplasms].
    Suba Z; Ujpál M
    Magy Onkol; 2006; 50(2):127-35. PubMed ID: 16888676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
    Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):850-5. PubMed ID: 15824155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Healthy life style seems to reduce the risk of cancer. New support for the hypothesis that overweight and high blood glucose increase the cancer risk].
    Stocks T; Lindahl B; Stattin P
    Lakartidningen; 2007 Dec; 104(51-52):3867-70. PubMed ID: 18232528
    [No Abstract]   [Full Text] [Related]  

  • 15. Body fatness, related biomarkers and cancer risk: an epidemiological perspective.
    Nimptsch K; Pischon T
    Horm Mol Biol Clin Investig; 2015 May; 22(2):39-51. PubMed ID: 25781710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does metabolic health in overweight and obesity persist? - Individual variation and cardiovascular mortality over two decades.
    Kaur A; Johnston DG; Godsland IF
    Eur J Endocrinol; 2016 Aug; 175(2):133-43. PubMed ID: 27412654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid system and cardiometabolic risk.
    Saavedra LE
    Clin Pharmacol Ther; 2007 Nov; 82(5):591-4. PubMed ID: 17898706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and cancer: a 2013 synopsis.
    Buysschaert M; Sadikot S
    Diabetes Metab Syndr; 2013; 7(4):247-50. PubMed ID: 24290094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and colorectal cancer.
    Aleksandrova K; Nimptsch K; Pischon T
    Front Biosci (Elite Ed); 2013 Jan; 5(1):61-77. PubMed ID: 23276970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral obesity, metabolic syndrome, insulin resistance and cancer.
    Doyle SL; Donohoe CL; Lysaght J; Reynolds JV
    Proc Nutr Soc; 2012 Feb; 71(1):181-9. PubMed ID: 22051112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.